array:25 ["pii" => "S2254887419301882" "issn" => "22548874" "doi" => "10.1016/j.rceng.2019.07.009" "estado" => "S300" "fechaPublicacion" => "2020-03-01" "aid" => "1720" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "copyrightAnyo" => "2019" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2020;220:117-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0014256519302188" "issn" => "00142565" "doi" => "10.1016/j.rce.2019.07.011" "estado" => "S300" "fechaPublicacion" => "2020-03-01" "aid" => "1720" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2020;220:117-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "Editorial" "titulo" => "El dilema de la reducción de tratamiento en pacientes con asma moderado-grave controlados" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "117" "paginaFinal" => "118" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The dilemma of reducing treatment for patients with moderate-severe controlled asthma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S. Marín Romero, L. Jara Palomares" "autores" => array:2 [ 0 => array:2 [ "nombre" => "S." "apellidos" => "Marín Romero" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Jara Palomares" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2254887419301882" "doi" => "10.1016/j.rceng.2019.07.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887419301882?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256519302188?idApp=WRCEE" "url" => "/00142565/0000022000000002/v1_202002140803/S0014256519302188/v1_202002140803/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S225488741930178X" "issn" => "22548874" "doi" => "10.1016/j.rceng.2019.06.006" "estado" => "S300" "fechaPublicacion" => "2020-03-01" "aid" => "1712" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2020;220:119-20" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Editorial" "titulo" => "Exacerbation of chronic obstructive pulmonary disease. More than just forced expiratory volume and comorbidity" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "119" "paginaFinal" => "120" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Exacerbación en la enfermedad pulmonar obstructiva crónica. Algo más que el volumen espiratorio forzado y la comorbilidad" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. de la Fuente Aguado" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "de la Fuente Aguado" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256519301973" "doi" => "10.1016/j.rce.2019.06.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256519301973?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S225488741930178X?idApp=WRCEE" "url" => "/22548874/0000022000000002/v1_202002180732/S225488741930178X/v1_202002180732/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2254887420300151" "issn" => "22548874" "doi" => "10.1016/j.rceng.2020.01.001" "estado" => "S300" "fechaPublicacion" => "2020-03-01" "aid" => "1787" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2020;220:115-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Editorial" "titulo" => "A novel coronavirus emerges" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "115" "paginaFinal" => "116" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Un nuevo coronavirus emerge" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:2 [ 0 => array:2 [ "autoresLista" => "J. Ena" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Ena" ] ] ] 1 => array:2 [ "autoresLista" => "R.P. Wenzel" "autores" => array:1 [ 0 => array:2 [ "nombre" => "R.P." "apellidos" => "Wenzel" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256520300217" "doi" => "10.1016/j.rce.2020.01.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256520300217?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887420300151?idApp=WRCEE" "url" => "/22548874/0000022000000002/v1_202002180732/S2254887420300151/v1_202002180732/en/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S2254887419301304" "issn" => "22548874" "doi" => "10.1016/j.rceng.2019.05.002" "estado" => "S300" "fechaPublicacion" => "2020-03-01" "aid" => "1679" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Clin Esp. 2020;220:79-85" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Social and clinical predictors associated with prolonged hospital stays for patients with severe exacerbation of chronic obstructive pulmonary disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "79" "paginaFinal" => "85" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Predictores sociales y clínicos asociados con estancia hospitalaria prolongada en pacientes con agudización grave de EPOC" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S. Fernández-García, C. Represas-Represas, A. Ruano-Raviña, M. Botana-Rial, C. Mouronte-Roibas, C. Ramos-Hernández, A. Fernández Villar" "autores" => array:7 [ 0 => array:2 [ "nombre" => "S." "apellidos" => "Fernández-García" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Represas-Represas" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Ruano-Raviña" ] 3 => array:2 [ "nombre" => "M." "apellidos" => "Botana-Rial" ] 4 => array:2 [ "nombre" => "C." "apellidos" => "Mouronte-Roibas" ] 5 => array:2 [ "nombre" => "C." "apellidos" => "Ramos-Hernández" ] 6 => array:2 [ "nombre" => "A." "apellidos" => "Fernández Villar" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256519301493" "doi" => "10.1016/j.rce.2019.05.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256519301493?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887419301304?idApp=WRCEE" "url" => "/22548874/0000022000000002/v1_202002180732/S2254887419301304/v1_202002180732/en/main.assets" ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Editorial" "titulo" => "The dilemma of reducing treatment for patients with moderate-severe controlled asthma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "117" "paginaFinal" => "118" ] ] "autores" => array:2 [ 0 => array:3 [ "autoresLista" => "S. Marín Romero" "autores" => array:1 [ 0 => array:2 [ "nombre" => "S." "apellidos" => "Marín Romero" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocío, Sevilla, Spain" "identificador" => "aff0005" ] ] ] 1 => array:4 [ "autoresLista" => "L. Jara Palomares" "autores" => array:1 [ 0 => array:4 [ "nombre" => "L." "apellidos" => "Jara Palomares" "email" => array:1 [ 0 => "luisoneumo@hotmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "b" "identificador" => "aff0015" ] 2 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocío, Sevilla, Spain" "etiqueta" => "a" "identificador" => "aff0010" ] 1 => array:3 [ "entidad" => "CIBERES, Instituto de Salud Carlos III, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author at: Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocío, Sevilla, Spain." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El dilema de la reducción de tratamiento en pacientes con asma moderado-grave controlados" ] ] "textoCompleto" => "Asthma is a significant public health problem that affects all ages, and its prevalence is increasing in many countries, with a predominant increase in children. Asthma currently incurs significant healthcare expenditures due to its morbidity and mortality and from an economic standpoint. However, a reduction in mortality and hospitalizations has been observed in a number of countries. The objective of asthma treatment is maintaining control for long periods.<a class="elsevierStyleCrossRefs" href="#bib0005">1–3</a> International guidelines recommend gradually decreasing the treatment once the asthma has been controlled for at least 3 months, so as to find the minimum therapeutic needs required to maintain control (step-down therapy). However, this suggestion has a low level of evidence.<a class="elsevierStyleCrossRefs" href="#bib0005">1–3</a> A meta-analysis in the Cochrane journal concluded that adults undergoing treatment with long-acting β2-adrenergic agonists (LABA) and inhaled corticosteroids (ICS) for whom the treatment with the LABA was suspended had an increased likelihood of asthmatic exacerbations.<a class="elsevierStyleCrossRef" href="#bib0020">4</a>In this issue of the journal, we present an interesting study that analyzed the factors that determined the loss of control when conducting step-down therapy when treating moderate-severe asthma with a combination of ICS and LABA. This retrospective multicenter study analyzed 374 patients and found that the therapy failed for 41.7% of the patients, defining failure as the need to increase the treatment, loss of asthma control measured by an asthma control test (ACT) score<20 and/or the presence of exacerbation. This study identified the following factors related to treatment failure: age (the greater the age, the higher the risk), severe asthma (compared with moderate asthma) and asthma controlled for less than 6 months. Although the study had the limitation of being retrospective, it helps identify the factors to consider when deciding to reduce the treatment, although these findings need to be confirmed in prospective studies or clinical trials.Recently, Pérez de Llano et al. conducted a prospective, multicenter study on adult patients with controlled asthma, analyzing variables associated with the failure of step-down therapy.<a class="elsevierStyleCrossRef" href="#bib0025">5</a> The authors analyzed 228 patients in the derivation cohort (495 episodes of step-down therapy) and identified the following factors associated with step-down therapy failure: a forced expiratory volume in one second (FEV1)/ forced vital capacity (FVC) ratio<70% (+2.5 points), an FEV1<80% of the theoretical value (+2 points), 1 or more severe exacerbations in the past year (+3 points) and an ACT score <25 (+2.5 points). According to this scale, the patients with a score <4.5 points had a risk of step-down therapy failure of <20%, and those with a score >8 had a >40% risk of step-down therapy failure. Nevertheless, this scale needs to be validated in a different prospective cohort to have external validity.In conclusion, asthma is a complex disease to manage and requires follow-up, especially to maintain good symptom control. However, for those patients with good disease control, we face the challenge of deciding when to conduct step-down therapy and what tools to use." "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2019-07-19" "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "Please cite this article as: Marín Romero S, Jara Palomares L. El dilema de la reducción de tratamiento en pacientes con asma moderado-grave controlados. Rev Clin Esp. 2020;220:117–118." ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global Strategy for Asthma Management and Prevention 2019 update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Global Initiative for Asthma" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2019" "paginaInicial" => "1" "paginaFinal" => "199" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comité Ejecutivo de GEMA. [GEMA(4.0). Guidelines for Asthma Management]" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "V. Plaza Moral" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0300-2896(15)32812-X" "Revista" => array:7 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2015" "volumen" => "51" "numero" => "Suppl 1" "paginaInicial" => "2" "paginaFinal" => "54" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26707419" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spanish guideline on the management of asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V. Plaza Moral" 1 => "S. Alonso Mostaza" 2 => "C. Alvarez Rodríguez" 3 => "A. Gomez-Outes" 4 => "F. Gómez Ruiz" 5 => "A. López Vina" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.18176/jiaci.0065" "Revista" => array:7 [ "tituloSerie" => "J Investig Allergol Clin Immunol" "fecha" => "2016" "volumen" => "26" "numero" => "Suppl 1" "paginaInicial" => "1" "paginaFinal" => "92" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27220197" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Ahmad" 1 => "K.M. Kew" 2 => "R. Normansell" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2015" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A simple score for future risk prediction in patients with controlled asthma who undergo a guidelines-based step-down strategy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Pérez de Llano" 1 => "J.L. García-Rivero" 2 => "I. Urrutia" 3 => "E. Martínez-Moragón" 4 => "J. Ramos" 5 => "P. Cebollero" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaip.2018.10.017" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol Pract" "fecha" => "2019" "volumen" => "7" "paginaInicial" => "1214" "paginaFinal" => "1221" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30368006" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22548874/0000022000000002/v1_202002180732/S2254887419301882/v1_202002180732/en/main.assets" "Apartado" => array:4 [ "identificador" => "72714" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorials" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22548874/0000022000000002/v1_202002180732/S2254887419301882/v1_202002180732/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887419301882?idApp=WRCEE"]

Revista Clínica Española (English Edition)

ISSN: 2254-8874

Revista Clínica Española published its first issue in 1940 and is the body of expression of the Spanish Society of Internal Medicine (SEMI).
The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Revista Clínica Española is subject to a thorough double blind review of the received articles written in Spanish or English. Ten issues are published each year, including mostly originals, reviews and consensus documents.

Indexed in:

Current Contents / Clinical Medicine , JCR / SCI-Expanded, Index Medicus / Medline y Excerpta Medica / EMBASE

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.3

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

0.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.162

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.211

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Lee este artículo en Español

Export reference

Download PDF

Purchase article

For the purchase of this article it is necessary to fill in the following form:

Name *

First surname *

Second surname

Email *

Address *

Number *

City *

Afganistan

Albania

Alemania

Andorra

Angola

Anguilla

Antartica

Antigua and barbuda

Antillas holandesas

Arabia saudita

Argelia

Argentina

Armenia

Aruba

Australia

Austria

Azerbaijan

Bahamas

Bahrain

Bangladesh

Barbados

Belarus

Belgica

Belice

Benin

Bermudas/antillas britanicas

Bhutan

Bolivia

Bosnia y herzegowina

Botswana

Brasil

Brunei darussalam

Bulgaria

Burkina faso

Burundi

Cabo verde

Camboya

Camerun

Canada

Chad

Chile

China

Chipre

Colombia

Comoros

Corea

Costa rica

Cote d´ivoire

Croacia

Cuba

Dinamarca

Djibouti

Dominica

East timor

Ecuador

Egipto

El salvador

Emiratos arabes unidos

Eritrea

Escocia

Eslovaquia

Eslovenia

España

Estados federados de micronesia

Estados unidos

Estonia

Etiopia

Fiji

Filipinas

Finlandia

Francia

Gabon

Gambia

Georgia

Ghana

Gibraltar

Grecia

Grenada

Groenlandia

Guadalupe

Guam

Guatemala

Guayana britanica

Guinea

Guinea ecuatorial

Guinea francesa

Guinea-bissau

Haiti

Holanda

Honduras

Hong kong

Hungria

India

Indonesia

Irak

Iran

Irlanda

Isla bouvet

Isla cocos (keeling)

Isla cook

Isla mauricio

Isla navidad

Isla norfolk

Islandia

Islas caiman

Islas falkland (malvinas)

Islas faroe

Islas georgia del sur y sandwich

Islas heard and mc donald

Islas marshall

Islas northern mariana

Islas salomon

Islas svalbard and jan mayen

Islas turks and caicos

Islas united states minor outlyi

Islas virgenes (britanicas)

Islas virgenes (u.s.a.)

Islas wallis and futuna

Israel

Italia

Jamaica

Japon

Jordania

Kazakhstan

Kenia

Kiribati

Kuwait

Kyrgyzstan

Lesoto

Letonia

Libano

Liberia

Libia arab jamahiriya

Liechtenstein

Lituania

Luxemburgo

Macao

Macedonia

Madagascar

Malasia

Malawi

Maldives

Mali

Malta

Marruecos

Martinica

Mauritania

Mayotte

Mexico

Monaco

Mongolia

Monserrat

Morocco

Mozambique

Myanmar

Namibia

Nauru

Nepal

Nicaragua

Niger

Nigeria

Niue

Noruega

Nueva caledonia

Nueva zelanda

Oman

Pakistan

Palau

Panama

Papua new guinea

Paraguay

Peru

Pitcairn

Polinesia francesa

Polonia

Portugal

Posesiones gran bretaña

Posesiones u.s.a.

Puerto rico

Qatar

Reino unido

Republica checa

Republica de africa central

Republica de cabo verde

Republica de congo

Republica de corea

Republica de moldova

Republica democratica de laos

Republica democratica del congo

Republica dominicana

Reunion

Ruanda

Rumania

Rusia

Sahara occidental

Saint kitts and nevis

Samoa

Samoa americana

San marino

San tomas y principe

San vincent and the grenadines

Santa lucia

Senegal

Serbia

Seychelles

Sierra leona

Singapur

Siria

Somalia

Sri lanka

St. helena

St. pierre and miquelon

Sudafrica

Sudan

Suecia

Suiza

Surinam

Swaziland

Tailandia

Taiwan republica de china

Tajikistan

Tanzania

Territorio de indias britanicas

Togo

Tokelau

Tonga

Trinidad and tobago

Tunisia

Turkmenistan

Turquia

Tuvalu

Ucrania

Uganda

Uruguay

Uzbekistan

Vanuatu

Vaticano

Venezuela

Vietnam

Yemen

Yugoslavia

Zambia

Zimbawe

Lebanon

Paises bajos

A coruña

Alava

Albacete

Alicante

Almeria

Asturias

Avila

Badajoz

Balears

Barcelona

Bizkaia

Burgos

Caceres

Cadiz

Cantabria

Castellon

Ceuta

Ciudad real

Cordoba

Cuenca

Girona

Granada

Guadalajara

Guipuzcoa

Huelva

Huesca

Jaen

La rioja

Las palmas

Leon

Lleida

Lugo

Madrid

Malaga

Melilla

Murcia

Navarra

Ourense

Palencia

Pontevedra

Salamanca

Segovia

Sevilla

Soria

Tarragona

Tenerife

Teruel

Toledo

Valencia

Valladolid

Zamora

Zaragoza

-- Not applicable --

Código postal *

Phone *

NIF o número identificativo *

I accept to receive information about Elsevier's special products and promotions by email

I accept to receive information about products and special promotions from Elsevier partners by email

I have read and understand the Privacy Policy and Terms and conditions and agree to be bound by all of its terms.

* Required fields

In addition to temporary access to the article, it will be sent by email.

Customer Support

Phone

Calls from Spain

932 415 960

Calls from abroad

+34 932 415 960

Hours from 9 a.m. to 6 p.m. except the months of July and August, which will be from 9 am to 3 pm.

Highlighted articles

Recommendations of the Spanish-Portuguese Internal Medicine services in the fight against climate change and environmental degradation

Publish in

Revista Clínica Española

Free access articles

The value of multi-modal ultrasound in the assessment of...

Rev Clin Esp. 2024;224:437-44

Adverse cardiovascular, obstetric and perinatal events...

Rev Clin Esp. 2024;224:337-45

How to detect non-institutionalized older patients at risk...

Rev Clin Esp. 2024;224:217-24

Revista Clínica Española (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Indexed in:

Follow us:

Subscribe:

Purchase article

Subscribe to our newsletter